軟骨修復/再生の世界市場分析:治療法別(体細胞由来、体細胞非由来)、用途別(硝子軟骨、線維軟骨)、治療別(緩和、因性修復刺激)、状況別(膝軟骨修復)、セグメント予測、2014-2025...市場調査レポートについてご紹介

【英文タイトル】Cartilage Repair/Regeneration Market Analysis By Treatment Modality (Cell-Based, Non-Cell-Based), By Application (Hyaline Cartilage, Fibrocartilage), By Treatment Type (Palliative, Intrinsic Repair Stimulus), By Site (Knee Cartilage Repair), And Segment Forecasts, 2014-2025

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Chapter 1. Methodology and Scope
1.1. Information Procurement
1.1.1. Purchased database
1.1.2. GVR’s internal database
1.2. Data Analysis
1.3. Market Formulation & Validation
1.4. Primary Research
1.4.1. List of primary sources
1.5. Approaches for Market Estimation
1.5.1. Approach 1: Commodity flow & bottom-up approach
1.5.2. Approach 2: Top-down and parent market analysis
Chapter 2. Executive Summary
2.1. Market Snapshot, 2016
Chapter 3. Cartilage Repair/Regeneration Market Variables, Trends & Scope
3.1. Market Segmentation & Scope
3.2. Market Driver Analysis
3.3. Market Restraint Analysis
3.4. Penetration & Growth Prospect Mapping
3.5. SWOT Analysis, by Factor
3.5.1. Political
3.5.2. Economic
3.5.3. Technological
3.6. Industry Analysis – Porter’s
Chapter 4. Cartilage Repair/Regeneration Market: Treatment Modality Estimates & Trend Analysis
4.1. Treatment Modality Movement Analysis & Market Share, 2016 & 2025
4.2. Market Size Estimates & Forecasts and Trend Analyses, 2014 to 2025 for the following treatment modality:
4.2.1. Cell-based
4.2.1.1. Chondrocyte transplantation
4.2.1.1.1. Chondrocyte transplantation market estimates and forecasts, 2014 to 2025
4.2.1.2. Growth factor pharmacology
4.2.1.2.1. Growth factor technology market estimates and forecasts, 2014 to 2025
4.2.2. Non-Cell-based
4.2.2.1. Tissue scaffolds
4.2.2.1.1. Tissue scaffolds market estimates and forecasts, 2014 to 2025
4.2.2.2. Cell-free composites
4.2.2.2.1. Cell-free composites market estimates and forecasts, 2014 to 2025
Chapter 5. Cartilage Repair/Regeneration Market: Application Estimates & Trend Analysis
5.1. Application Movement Analysis & Market Share, 2016 & 2025
5.2. Market Size Estimates & Forecasts for the following application:
5.2.1. Hyaline cartilage
5.2.1.1. Hyaline cartilage market estimates and forecasts, 2014 to 2025
5.2.2. Fibrocartilage
5.2.2.1. Fibrocartilage market estimates and forecasts, 2014 to 2025
Chapter 6. Cartilage Repair/Regeneration Market: Treatment Type Estimates & Trend Analysis
6.1. Treatment Type Analysis & Market Share, 2016 & 2025
6.2. Market Size Estimates & Forecasts for the following treatment type:
6.2.1. Palliative
6.2.1.1. Viscosupplementation
6.2.1.1.1. Viscosupplementation market estimates and forecasts, 2014 to 2025
6.2.1.2. Debridement & Lavage
6.2.1.2.1. Debridement & lavage market estimates and forecasts, 2014 to 2025
6.2.2. Intrinsic repair stimulus
6.2.2.1. Intrinsic repair stimulus market estimates and forecasts, 2014 to 2025
Chapter 7. Cartilage Repair/Regeneration Market: Site Estimates & Trend Analysis
7.1. Site Movement Analysis & Market Share, 2016 & 2025
7.2. Market Size Estimates & Forecasts for the following site:
7.2.1. Knee cartilage repair
7.2.1.1. Knee cartilage repair market estimates and forecasts, 2014 to 2025
7.2.2. Other
7.2.2.1. Other market estimates and forecasts, 2014 to 2025
Chapter 8. Cartilage Repair/Regeneration Market: Regional Estimates & Trend Analysis
8.1. Regional Movement Analysis & Market Share, 2016 & 2025
8.2. North America
8.2.1. U.S.
8.2.1.1. U.S. revenue estimates and forecasts, by treatment modality 2014 – 2025 (USD Million)
8.2.1.2. U.S. revenue estimates and forecasts, by application 2014 – 2025 (USD Million)
8.2.1.3. U.S. revenue estimates and forecasts, by treatment type 2014 – 2025 (USD Million)
8.2.1.4. U.S. revenue estimates and forecasts, by technique 2014 – 2025 (USD Million)
8.2.2. Canada
8.2.2.1. Canada revenue estimates and forecasts, by treatment modality 2014 – 2025 (USD Million)
8.2.2.2. Canada revenue estimates and forecasts, by application 2014 – 2025 (USD Million)
8.2.2.3. Canada revenue estimates and forecasts, by treatment type 2014 – 2025 (USD Million)
8.2.2.4. Canada revenue estimates and forecasts, by site 2014 – 2025 (USD Million)
8.3. Europe
8.3.1. UK
8.3.1.1. UK revenue estimates and forecasts, by treatment modality 2014 – 2025 (USD Million)
8.3.1.2. UK revenue estimates and forecasts, by application 2014 – 2025 (USD Million)
8.3.1.3. UK revenue estimates and forecasts, by treatment type 2014 – 2025 (USD Million)
8.3.1.4. UK revenue estimates and forecasts, by site 2014 – 2025 (USD Million)
8.3.2. Germany
8.3.2.1. Germany revenue estimates and forecasts, by treatment modality 2014 – 2025 (USD Million)
8.3.2.2. Germany revenue estimates and forecasts, by application 2014 – 2025 (USD Million)
8.3.2.3. Germany revenue estimates and forecasts, by treatment type 2014 – 2025 (USD Million)
8.3.2.4. Germany revenue estimates and forecasts, by site 2014 – 2025 (USD Million)
8.4. Asia Pacific
8.4.1. Japan
8.4.1.1. Japan revenue estimates and forecasts, by treatment modality 2014 – 2025 (USD Million)
8.4.1.2. Japan revenue estimates and forecasts, by application 2014 – 2025 (USD Million)
8.4.1.3. Japan revenue estimates and forecasts, by treatment type 2014 – 2025 (USD Million)
8.4.1.4. Japan revenue estimates and forecasts, by site 2014 – 2025 (USD Million)
8.4.2. China
8.4.2.1. China revenue estimates and forecasts, by treatment modality 2014 – 2025 (USD Million)
8.4.2.2. China revenue estimates and forecasts, by application 2014 – 2025 (USD Million)
8.4.2.3. China revenue estimates and forecasts, by treatment type 2014 – 2025 (USD Million)
8.4.2.4. China revenue estimates and forecasts, by site 2014 – 2025 (USD Million)
8.5. Latin America
8.5.1. Brazil
8.5.1.1. Brazil revenue estimates and forecasts, by treatment modality 2014 – 2025 (USD Million)
8.5.1.2. Brazil revenue estimates and forecasts, by application 2014 – 2025 (USD Million)
8.5.1.3. Brazil revenue estimates and forecasts, by treatment type 2014 – 2025 (USD Million)
8.5.1.4. Brazil revenue estimates and forecasts, by site 2014 – 2025 (USD Million)
8.5.2. Mexico
8.5.2.1. Mexico revenue estimates and forecasts, by treatment modality 2014 – 2025 (USD Million)
8.5.2.2. Mexico revenue estimates and forecasts, by application 2014 – 2025 (USD Million)
8.5.2.3. Mexico revenue estimates and forecasts, by treatment type 2014 – 2025 (USD Million)
8.5.2.4. Mexico revenue estimates and forecasts, by site 2014 – 2025 (USD Million)
8.6. MEA
8.6.1. South Africa
8.6.1.1. South Africa revenue estimates and forecasts, by treatment modality 2014 – 2025 (USD Million)
8.6.1.2. South Africa revenue estimates and forecasts, by application 2014 – 2025 (USD Million)
8.6.1.3. South Africa revenue estimates and forecasts, by treatment type 2014 – 2025 (USD Million)
8.6.1.4. South Africa revenue estimates and forecasts, by site 2014 – 2025 (USD Million)
Chapter 9. Competitive Landscape
9.1. Strategy Framework
9.2. Company Profiles
9.2.1. Zimmer Biomet
9.2.1.1. Company overview
9.2.1.2. Financial performance
9.2.1.3. Product benchmarking
9.2.1.4. Strategic initiatives
9.2.2. Stryker Corporation
9.2.2.1. Company overview
9.2.2.2. Financial performance
9.2.2.3. Product benchmarking
9.2.2.4. Strategic initiatives
9.2.3. Depuy Synthes
9.2.3.1. Company overview
9.2.3.2. Financial performance
9.2.3.3. Product benchmarking
9.2.3.4. Strategic initiatives
9.2.4. Smith & Nephew plc
9.2.4.1. Company overview
9.2.4.2. Financial performance
9.2.4.3. Product benchmarking
9.2.4.4. Strategic initiatives
9.2.5. Vericel Corporation
9.2.5.1. Company overview
9.2.5.2. Financial Performance
9.2.5.3. Product benchmarking
9.2.5.4. Strategic initiatives
9.2.6. Osiris Therapeutics Inc.
9.2.6.1. Company overview
9.2.6.2. Financial performance
9.2.6.3. Product benchmarking
9.2.6.4. Strategic initiatives
9.2.7. B. Braun Melsungen AG
9.2.7.1. Company overview
9.2.7.2. Financial Performance
9.2.7.3. Product benchmarking
9.2.7.4. Strategic initiatives
9.2.8. Anika Therapeutics, Inc.
9.2.8.1. Company overview
9.2.8.2. Financial performance
9.2.8.3. Product benchmarking
9.2.8.4. Strategic initiatives
9.2.9. Arthrex, Inc.
9.2.9.1. Company overview
9.2.9.2. Financial performance
9.2.9.3. Product benchmarking
9.2.9.4. Strategic initiatives
9.2.10. Collagen Solutions Plc
9.2.10.1. Company overview
9.2.10.2. Financial performance
9.2.10.3. Product benchmarking
9.2.10.4. Strategic initiatives


【レポート販売概要】

■ タイトル:軟骨修復/再生の世界市場分析:治療法別(体細胞由来、体細胞非由来)、用途別(硝子軟骨、線維軟骨)、治療別(緩和、因性修復刺激)、状況別(膝軟骨修復)、セグメント予測、2014-2025
■ 英文:Cartilage Repair/Regeneration Market Analysis By Treatment Modality (Cell-Based, Non-Cell-Based), By Application (Hyaline Cartilage, Fibrocartilage), By Treatment Type (Palliative, Intrinsic Repair Stimulus), By Site (Knee Cartilage Repair), And Segment Forecasts, 2014-2025
■ 発行日:2017年5月16日
■ 調査会社:Grand View Research
■ 商品コード:GVIEW707169
■ 調査対象地域:グローバル
  • 世界における小型自動車用OE(メーカー純正部品)ミラー市場(2008-2028)
    This latest just-auto report edition offers a global review of the OE mirrors sector, its suppliers, top markets, technologies and market forecasts. This global market study offers: Automotive OE mirrors market size estimates Latest technologies and trends Market share data tables Exclusive interviews with major companies Profiles of the major players including their strategies and prospects Marke …
  • アブレーション技術の世界市場予測(~2021年):高周波、超音波、レーザー、電気、冷凍療法、マイクロ波、水熱
    The global ablation technology market is estimated to be valued at USD 2.82 Billion in 2016, growing at a CAGR of 10.9% between 2016 and 2021 and reach USD 4.73 Billion. On the basis of type, the market is categorized into laser/light, radiofrequency, ultrasound, electrical, cryoablation, microwave, and hydrothermal ablation technology. The radiofrequency ablation segment is estimated to command t …
  • 世界の腸疾患テスト市場動向(2014-2018)
    TechNavio's analysts forecast the Global Enteric Disease Testing market to grow at a CAGR of 2.83 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing incidence of enteric diseases. The Global Enteric Disease Testing market has also been witnessing the emergence of new pathogens causing infections. However, the stringent regulatory approval …
  • 声帯麻痺:治療薬の治験動向(2014年下半期)
    Vocal Cord Paralysis Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Vocal Cord Paralysis Global Clinical Trials Review, H2, 2014" provides data on the Vocal Cord Paralysis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Vocal Cord Paralysis. It includes an overview of the trial numbers and their r …
  • 豆粉の世界市場予測(~2022年):エンドウ、ビーン、ヒヨコマメ、レンズ豆
    The global pulse flours market witnessed steady growth over the last few years. The market size is projected to reach USD 18.97 Billion by 2022, at a CAGR of around 12.2% from 2017. High protein profile of pulses and demand for health food products have been major drivers contributing to the growth of the market. The pulse flours market, by type, is segmented into pea, bean, chickpea, and lentil. …
  • 心室頻拍(Ventricular Tachycardia):世界の治験レビュー(2015年上半期版)
    Ventricular Tachycardia Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Ventricular Tachycardia Global Clinical Trials Review, H1, 2015" provides data on the Ventricular Tachycardia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ventricular Tachycardia. It includes an overview of the trial numbers …
  • 果物・野菜加工機械の世界市場2017-2021
    About Fruit and Vegetable Processing Equipment Fruit and vegetable processing equipment are used by manufacturers for processing fruits and vegetables using techniques such as washing, dewatering, filling, seasoning, and packaging. Processing of fruits and vegetables using this equipment helps in the removal of toxins and increases their shelf life. Technavio’s analysts forecast the global fruit a …
  • 飼料工場市場:カンボジア
    This report is a comprehensive research of feed mill industry in Cambodia. The first two chapters of the report feature the country profile by giving general information on Cambodia and by thoroughly studying its economic state, (including key macroeconomic indicators and their development trends). The third chapter covers common business procedures in the country: from starting a project to closi …
  • MEK阻害剤の世界市場:メキニスト、コテリック、メクトビ
    Global MEK Inhibitors Market 2019-2023: About the market MEK is a drug that inhibits the mitogen-activated extracellular signal-regulated kinase. Technavio’s MEK inhibitors market analysis considers sale from MEKINIST, COTELLIC, and MEKTOVI. Our analysis also considers the MEK inhibitors in Asia, Europe, North America, and ROW. In 2018, the MEKINIST segment had a significant share, and this trend …
  • SoI(システムオヴインサイト)の世界市場予測(~2024年)
    The global system of insight market size to grow at a Compound Annual Growth Rate (CAGR) of 22.2% during the forecast periodThe global system of insight market size is expected to grow from USD 1.2 billion in 2019 to USD 3.4 billion by 2024, at a Compound Annual Growth Rate (CAGR) of 22.2% during the forecast period. The major factors expected to drive the growth of the system of insight market in …
  • 世界主要国のレジオネラ菌検査(医療機器)市場:サプライヤーシェア及び市場予測
    The report presents a detailed analysis of the Legionella diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Legionella definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments:     - Hospitals     - Co …
  • 世界のデジタル映画スクリーン市場動向(2012-2016)
    TechNavio's analysts forecast the Global Digital Cinema Screen market to grow at a CAGR of 11.45 percent over the period 2012-2016. One of the key factors contributing to this market growth is the cost reduction and benefits for film producers. The Global Digital Cinema Screen market has also been witnessing the electronic distribution of movies. However, the high initial cost could pose a challen …
  • Post-Operative Pain:グローバル臨床試験レビューH1, 2013
    Post-Operative Pain Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Post-Operative Pain Global Clinical Trials Review, H1, 2013" provides data on the Post-Operative Pain clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Post-Operative Pain. It includes an overview of the trial numbers and their recru …
  • Eゲート(自動化ゲート)の世界市場2018-2022
    About E-Gates E-gates is a system available at the arrival and the departure-gates of the airport, which helps validate the identity of the passengers using various technologies such as iris scanning, fingerprint scanning, and face scanning. Technavio’s analysts forecast the global e-gates market to grow at a CAGR of 18.78% during the period 2018-2022. Covered in this report The report covers the …
  • Penn West Exploration:石油・ガスの開発・生産動向及びコスト分析- Q3, 2013
    Penn West Exploration Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Penn West Exploration Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。